|
1
|
International Agency for Research on
Cancer, . GLOBOCAN 2012: Estimated cancer incidence, mortality and
prevalence worldwide in 2012. http://globocan.iarc.fr/Pages/fact_sheets_population.aspxDecember
30–2014
|
|
2
|
NCCN, . Clinical practice guidelines in
oncology head and neck cancers. Version 2. http://www.nccn.org/professionals/physician_gls/f_guidelines.aspDecember
30–2014
|
|
3
|
Nagata M, Noman AA, Suzuki K, Kurita H,
Ohnishi M, Ohyama T, Kitamura N, Kobayashi T, Uematsu K, Takahashi
K, et al: ITGA3 and ITGB4 expression biomarkers estimate the risks
of locoregional and hematogenous dissemination of oral squamous
cell carcinoma. BMC Cancer. 13:4102013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nagata M, Fujita H, Ida H, Hoshina H,
Inoue T, Seki Y, Ohnishi M, Ohyama T, Shingaki S, Kaji M, et al:
Identification of potential biomarkers of lymph node metastasis in
oral squamous cell carcinoma by cDNA microarray analysis. Int J
Cancer. 106:683–689. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kurokawa A, Nagata M, Kitamura N, Noman
AA, Ohnishi M, Ohyama T, Kobayashi T, Shingaki S and Takagi R:
Oral, Maxillofacial Pathology and Surgery Group: Diagnostic value
of integrin alpha3, beta4 and beta5 gene expression levels for the
clinical outcome of tongue squamous cell carcinoma. Cancer.
112:1272–1281. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen X, Zhang FH, Chen QE, Wang YY, Wang
YL, He JC and Zhou J: The clinical significance of CDK1 expression
in oral squamous cell carcinoma. Med Oral Patol Oral Cir Bucal.
20:e7–e12. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bonelli P, Tuccillo FM, Borrelli A,
Schiattarella A and Buonaguro FM: CDK/CCN and CDKI alterations for
cancer prognosis and therapeutic predictivity. BioMed Res Int.
2014:3610202014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Malumbres M and Barbacid M: Cell cycle
kinases in cancer. Curr Opin Genet Dev. 17:60–65. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yamamoto E, Kohama G, Sunakawa H, Iwai M
and Hiratsuka H: Mode of invasion, bleomycin sensitivity, and
clinical course in squamous cell carcinoma of the oral cavity.
Cancer. 51:2175–2180. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Malumbres M: Physiological relevance of
cell cycle kinases. Physiol Rev. 91:973–1007. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shintani S, Mihara M, Nakahara Y, Kiyota
A, Ueyama Y, Matsumura T and Wong DT: Expression of cell cycle
control proteins in normal epithelium, premalignant and malignant
lesions of oral cavity. Oral Oncol. 38:235–243. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chang JT, Wang HM, Chang KW, Chen WH, Wen
MC, Hsu YM, Yung BY, Chen IH, Liao CT, Hsieh LL, et al:
Identification of differentially expressed genes in oral squamous
cell carcinoma (OSCC): Overexpression of NPM, CDK1 and NDRG1 and
underexpression of CHES1. Int J Cancer. 114:942–949. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
De Boer L, Oakes V, Beamish H, Giles N,
Stevens F, Somodevilla-Torres M, Desouza C and Gabrielli B: Cyclin
A/cdk2 coordinates centrosomal and nuclear mitotic events.
Oncogene. 27:4261–4268. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dong Y, Sui L, Tai Y, Sugimoto K and
Tokuda M: The overexpression of cyclin-dependent kinase (CDK) 2 in
laryngeal squamous cell carcinomas. Anticancer Res. 21:103–108.
2001.PubMed/NCBI
|
|
15
|
Pérez-Sayáns M, Suárez-Peñaranda JM,
Gayoso-Diz P, Barros-Angueira F, Gándara-Rey JM and García-García
A: The role of p21Waf1/CIP1 as a Cip/Kip type cell-cycle regulator
in oral squamous cell carcinoma (Review). Med Oral Patol Oral Cir
Bucal. 18:e219–e225. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kudo Y, Kitajima S, Ogawa I, Miyauchi M
and Takata T: Down-regulation of Cdk inhibitor p27 in oral squamous
cell carcinoma. Oral Oncol. 41:105–116. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bandoh N, Hayashi T, Takahara M, Kishibe
K, Ogino T, Katayama A, Imada M, Nonaka S and Harabuchi Y: Loss of
p21 expression is associated with p53 mutations and increased cell
proliferation and p27 expression is associated with apoptosis in
maxillary sinus squamous cell carcinoma. Acta Otolaryngol.
125:779–785. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ohashi K, Nemoto T, Eishi Y, Matsuno A,
Nakamura K and Hirokawa K: Expression of the cyclin dependent
kinase inhibitor p21WAF1/CIP1 in oesophageal squamous cell
carcinomas. Virchows Arch. 430:389–395. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gao L, Gu W, Zheng J, Ren W, Chang S, Wang
X, Li S, Song T, Huang C and Zhi K: Clinicopathological and
prognostic significance of p27 expression in oral squamous cell
carcinoma: A meta-analysis. Int J Biol Markers. 28:e329–e335. 2013.
View Article : Google Scholar : PubMed/NCBI
|
